GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.
Verdant Scientific is developing a first-in-class, first-in-approach small molecule for the treatment of atopic dermatitis, more commonly known as eczema, which is poised to completely change the treatment of this chronic, inflammatory skin condition, which affects over 200 million people worldwide.
Labor and Delivery technology that improves risk prediction 10x for postpartum hemorrhage, saving lives, reducing maternal complications and cutting obstetrics costs for health systems and payers.
We create human-mimicking artificial tumors for high-throughput drug screening, enabling more accurate identification of promising drugs during the preclinical stage.
Moleculera Biosciences is a precision diagnostics company pioneering clinical diagnostics services for inflammatory brain and cardiovascular disorders using an integrated business model. The company enables clinicians to accurately diagnose, treat, and monitor patients suffering from chronic immune-mediated disorders, leading to remarkable recoveries.
Key highlights include:
Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.
Hand Technologies, LLC (HAND) is a startup committed to developing and commercializing high-performance polymers and ultra-high temperature carbon/ceramic materials for the U.S. aerospace and defense market.
We developed SANDI (Simulator for Advanced Neurodiverse Driving Instruction), an AI-driven virtual reality driving simulator designed to help individuals on the autism spectrum build confidence, learn driving skills, and overcome driving anxiety through adaptive training and physiological feedback systems.
We are making the world more accessible by giving transportation businesses the Artificial Intelligence they need for vehicle scheduling, routing, and energy-use management.
Augment Health is developing a noninvasive bladder monitor and AI algorithm for 7M patients with bladder dysfunction following neurologic disease or injury, a $10.2B market.
